Given that FDA failed to identify a public health basis for why this lengthy proposal was necessary at this point in time, the letter’s authors ask FDA to answer questions justifying the expenditure of the agency’s limited resources on this effort.

MEMBERS OF CONGRESS QUESTION FDA PROPOSAL DESIGNED TO CREATE LIABILITY SHIELD FOR DRUG AND DEVICE COMPANIES
ORGANIZATIONS IN THIS STORY
ORGANIZATIONS IN THIS STORY